ATE356832T1 - Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100 - Google Patents

Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100

Info

Publication number
ATE356832T1
ATE356832T1 AT03748180T AT03748180T ATE356832T1 AT E356832 T1 ATE356832 T1 AT E356832T1 AT 03748180 T AT03748180 T AT 03748180T AT 03748180 T AT03748180 T AT 03748180T AT E356832 T1 ATE356832 T1 AT E356832T1
Authority
AT
Austria
Prior art keywords
apo
apolipoprotein
methods
detecting
compositions
Prior art date
Application number
AT03748180T
Other languages
German (de)
English (en)
Inventor
Jamila Najib
Zouher Majd
Original Assignee
Genfit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfit filed Critical Genfit
Application granted granted Critical
Publication of ATE356832T1 publication Critical patent/ATE356832T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Light Receiving Elements (AREA)
AT03748180T 2002-06-19 2003-06-19 Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100 ATE356832T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0207542A FR2841249A1 (fr) 2002-06-19 2002-06-19 Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100

Publications (1)

Publication Number Publication Date
ATE356832T1 true ATE356832T1 (de) 2007-04-15

Family

ID=29719858

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03748180T ATE356832T1 (de) 2002-06-19 2003-06-19 Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100

Country Status (11)

Country Link
US (1) US20050152900A1 (enExample)
EP (1) EP1513878B1 (enExample)
JP (1) JP2006515561A (enExample)
AT (1) ATE356832T1 (enExample)
AU (1) AU2003267493A1 (enExample)
CA (1) CA2489057A1 (enExample)
DE (1) DE60312513T2 (enExample)
DK (1) DK1513878T3 (enExample)
ES (1) ES2283803T3 (enExample)
FR (1) FR2841249A1 (enExample)
WO (1) WO2004000884A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005093415A1 (ja) * 2004-03-29 2008-02-14 株式会社シバヤギ アポリポタンパク質ｂ−４８の測定方法およびその用途
WO2007058588A1 (en) * 2005-11-18 2007-05-24 T.A.C Thrombosis And Coagulation Aktiebolag Monoclonal antibodies against apolipoprotein m
JP2009531712A (ja) * 2006-03-23 2009-09-03 デ グスマン ブレイヤー、エメリタ アポリポタンパク質フィンガープリント技術
US8088593B2 (en) 2007-10-02 2012-01-03 Theranos, Inc. Modular point-of-care devices, systems, and uses thereof
JP5832723B2 (ja) * 2009-03-06 2015-12-16 協和メデックス株式会社 可溶性インターロイキン−２受容体定量用標準品
EP2408812B1 (en) * 2009-03-17 2015-12-16 CardioVax, LLC Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions
WO2011060329A1 (en) 2009-11-14 2011-05-19 Kuang-Yuh Chyu Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis
US8506964B2 (en) 2010-02-05 2013-08-13 Cardiovax, Llc Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
RU2013126628A (ru) 2010-11-12 2014-12-20 Седарс-Синаи Медикал Сентер Иммуномодулирующие способы и системы для лечения и/или предотвращения аневризм
CA2817543A1 (en) 2010-11-12 2012-06-07 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of hypertension
CN106323875B (zh) 2011-01-21 2019-07-09 西拉诺斯知识产权有限责任公司 样品使用最大化的系统和方法
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US9268915B2 (en) 2011-09-25 2016-02-23 Theranos, Inc. Systems and methods for diagnosis or treatment
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
US11008628B1 (en) 2013-02-18 2021-05-18 Labrador Diagnostics Llc Systems and methods for analyte testing and laboratory oversight
US10401373B1 (en) 2013-02-18 2019-09-03 Theranos Ip Company, Llc Systems and methods for analyte testing and laboratory oversight
US10422806B1 (en) 2013-07-25 2019-09-24 Theranos Ip Company, Llc Methods for improving assays of biological samples
US11360107B1 (en) 2014-02-25 2022-06-14 Labrador Diagnostics Llc Systems and methods for sample handling
CN106053793A (zh) * 2016-06-20 2016-10-26 诺莱生物医学研究院（北京）有限公司 一种快速检测乳糜血的免疫层析试纸卡及其制备方法
WO2025111449A1 (en) * 2023-11-21 2025-05-30 Sun Diagnostics, Inc. Method and reagent to clear turbidity due to elevated triglycerides in a biological specimen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60193926A (ja) * 1984-03-15 1985-10-02 Tokyo Daigaku 単クローン性抗ヒトアポリポ蛋白質ｂ１００抗体
JPS617299A (ja) * 1984-06-20 1986-01-13 Dai Ichi Pure Chem Co Ltd ヒトアポリポ蛋白ｂ４８に高い特異性を有する単クローン性抗体
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors

Also Published As

Publication number Publication date
WO2004000884A2 (fr) 2003-12-31
DE60312513D1 (de) 2007-04-26
FR2841249A1 (fr) 2003-12-26
ES2283803T3 (es) 2007-11-01
DK1513878T3 (da) 2007-07-16
AU2003267493A1 (en) 2004-01-06
US20050152900A1 (en) 2005-07-14
DE60312513T2 (de) 2007-12-06
CA2489057A1 (fr) 2003-12-31
EP1513878A2 (fr) 2005-03-16
EP1513878B1 (fr) 2007-03-14
JP2006515561A (ja) 2006-06-01
WO2004000884A3 (fr) 2004-04-08

Similar Documents

Publication Publication Date Title
DE60312513D1 (de) Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100
WO2003106964A3 (en) High throughput methods and devices for assaying analytes in a fluid sample
ES2054617T3 (es) Nuevo metodo para la deteccion y/o determinacion cuantitativa de agentes ligantes especificos y sus correspondientes sustancias ligables.
EP1312919A3 (en) Sample volume metering apparatus
TW200606420A (en) Biosensors having improved sample application and uses thereof
BR9710836A (pt) Ensaio de analitos usando marcas em partìculas
DE60204418D1 (de) "High-Density-Lipoprotein"-Testvorrichtung und Verfahren
WO2003057851A3 (en) Binding proteins as biosensors
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
ATE522812T1 (de) Verfahren und zusammensetzung zum bestimmen von homocystein
GB9804083D0 (en) Immunoassays
ATE151883T1 (de) Verfahren zum nachweis freier igf-i, igf-ii, und gh spiegel in körperflüssigkeiten
CA2519504A1 (en) Combination assay for alcohol and drugs of abuse
ATE333510T1 (de) Enzymatische messung von mycophenolsäure
DE60318435D1 (de) Universeller biosensor und verfahren zur verwendung
AU1259801A (en) Detection method by pcr
DE60310012D1 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
Mani et al. Diagnostic kits: An aid to periodontal diagnosis
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE60131281D1 (de) Verfahren zum messen von gesamt-homocystein
Bosch et al. A rapid solid-phase fluorimetric assay for measuring bacterial adherence, using DNA-binding stains
ATE500505T1 (de) Enzymhemmungsimmunverfahren
CA2586654A1 (en) Use of asc as a marker for colorectal cancer
WO2002098919A3 (en) Method for apo ciii measurement in apob and non apob containing particles
ATE347108T1 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1513878

Country of ref document: EP

REN Ceased due to non-payment of the annual fee